Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Protara Therapeutics Inc., 3 years.
Protara Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 4, 2025 | Prelude Therapeutics Incorporated | Option exercise | +9,375 | — | — |
| Oct 4, 2025 | Prelude Therapeutics Incorporated | Shares withheld for tax | −3,355 | $1.47 | $4,932 |
| Jul 4, 2025 | Prelude Therapeutics Incorporated | Option exercise | +9,375 | — | — |
| Jul 4, 2025 | Prelude Therapeutics Incorporated | Shares withheld for tax | −3,355 | $0.79 | $2,650 |
| Apr 4, 2025 | Prelude Therapeutics Incorporated | Option exercise | +9,375 | — | — |
| Apr 4, 2025 | Prelude Therapeutics Incorporated | Shares withheld for tax | −3,355 | $0.68 | $2,281 |
| Jan 4, 2025 | Prelude Therapeutics Incorporated | Option exercise | +9,375 | — | — |
| Jan 4, 2025 | Prelude Therapeutics Incorporated | Shares withheld for tax | −3,859 | $1.39 | $5,364 |
| Oct 4, 2024 | Prelude Therapeutics Incorporated | Option exercise | +9,375 | — | — |
| Oct 4, 2024 | Prelude Therapeutics Incorporated | Shares withheld for tax | −3,349 | $2.00 | $6,698 |
| Jul 4, 2024 | Prelude Therapeutics Incorporated | Option exercise | +9,375 | — | — |
| Jul 4, 2024 | Prelude Therapeutics Incorporated | Shares withheld for tax | −3,347 | $3.60 | $12,049 |
| Apr 4, 2024 | Prelude Therapeutics Incorporated | Option exercise | +9,375 | — | — |
| Apr 4, 2024 | Prelude Therapeutics Incorporated | Shares withheld for tax | −3,347 | $4.74 | $15,865 |
| Jan 4, 2024 | Prelude Therapeutics Incorporated | Option exercise | +9,375 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.